RNA's Advantages Over Other Cell Therapies with Cartesian's CSO
Jan 06, 2022•20 min•Season 1Ep. 14
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
We love to hear from our listeners. Send us a message.
Dr. Michael Singer, CSO at Cartesian Therapeutics, details why RNA has advantages over other cell therapies, the company's three RNA trials, and the therapeutic benefit of multiple modifications.
For the best experience, listen in Metacast app for iOS or Android